PPARγ,USP2

Hao Luo1,2, Chujiao Zhu3, Yingying Wang3

  • 1Institute for Translational Medicine on Cell Fate and Disease, Shanghai Ninth People's Hospital, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. luohao@sdsmu.edu.cn.

PubMed
概括

乌比基特异性蛋白酶2 (USP2) 通过稳定PPARγ,驱动与代谢功能障碍相关的脂肪性肝病 (MASLD). 抑制USP2显示出治疗这种常见肝病的治疗潜力.